New scan could reveal if lung scarring drugs are working
NCT ID NCT05241275
Summary
This study is testing a special type of MRI scan to see if it can detect changes in lung scarring. It will enroll 60 adults with progressive lung scarring who are starting or considering anti-scarring medication. Participants will have the MRI scan before starting treatment and again at 3, 6, and 12 months to see if the scan can measure how the disease responds.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IDIOPATHIC PULMONARY FIBROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Duke University
Durham, North Carolina, 27710, United States
Conditions
Explore the condition pages connected to this study.